Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hand Hygiene | 7 | 2025 | 12 | 2.100 |
Why?
|
| Infection Control | 6 | 2025 | 130 | 1.550 |
Why?
|
| Guideline Adherence | 4 | 2025 | 236 | 1.220 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2016 | 5 | 1.000 |
Why?
|
| Cross Infection | 6 | 2025 | 155 | 0.940 |
Why?
|
| Attitude of Health Personnel | 5 | 2021 | 660 | 0.880 |
Why?
|
| Anaphylaxis | 1 | 2023 | 30 | 0.780 |
Why?
|
| Disease Outbreaks | 3 | 2021 | 150 | 0.650 |
Why?
|
| Communicable Diseases | 2 | 2023 | 69 | 0.620 |
Why?
|
| Simulation Training | 1 | 2019 | 107 | 0.540 |
Why?
|
| Hand Disinfection | 2 | 2021 | 18 | 0.530 |
Why?
|
| Drug Utilization | 1 | 2016 | 64 | 0.480 |
Why?
|
| Sorbitol | 1 | 2016 | 9 | 0.480 |
Why?
|
| Foodborne Diseases | 1 | 2016 | 9 | 0.480 |
Why?
|
| APACHE | 1 | 2015 | 23 | 0.460 |
Why?
|
| Health Personnel | 4 | 2021 | 234 | 0.450 |
Why?
|
| Gastrointestinal Diseases | 1 | 2016 | 149 | 0.430 |
Why?
|
| Social Media | 1 | 2016 | 111 | 0.420 |
Why?
|
| Human Activities | 1 | 2013 | 12 | 0.410 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 43 | 0.410 |
Why?
|
| Education, Medical | 1 | 2016 | 228 | 0.410 |
Why?
|
| Telemetry | 1 | 2013 | 30 | 0.400 |
Why?
|
| Clostridium Infections | 3 | 2023 | 128 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 557 | 0.380 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 492 | 0.370 |
Why?
|
| Hospital Mortality | 1 | 2015 | 482 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 836 | 0.370 |
Why?
|
| Patient Discharge | 1 | 2015 | 356 | 0.360 |
Why?
|
| Critical Care | 1 | 2015 | 444 | 0.350 |
Why?
|
| Intensive Care Units | 1 | 2015 | 454 | 0.350 |
Why?
|
| Influenza, Human | 3 | 2018 | 347 | 0.270 |
Why?
|
| Humans | 29 | 2025 | 93515 | 0.240 |
Why?
|
| Hospitals | 4 | 2025 | 328 | 0.230 |
Why?
|
| Influenza Vaccines | 2 | 2018 | 168 | 0.220 |
Why?
|
| Universities | 1 | 2021 | 150 | 0.160 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 579 | 0.160 |
Why?
|
| Students | 1 | 2021 | 179 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2020 | 108 | 0.150 |
Why?
|
| Warts | 1 | 2019 | 12 | 0.150 |
Why?
|
| Heterocyclic Compounds | 1 | 2019 | 19 | 0.150 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 39 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 118 | 0.140 |
Why?
|
| Academic Medical Centers | 3 | 2020 | 394 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 49 | 0.140 |
Why?
|
| Chicago | 3 | 2021 | 1464 | 0.140 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 19 | 0.140 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 87 | 0.140 |
Why?
|
| Bone Marrow | 1 | 2019 | 409 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2019 | 298 | 0.130 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 62 | 0.130 |
Why?
|
| Candida | 1 | 2016 | 20 | 0.130 |
Why?
|
| Culture Techniques | 1 | 2016 | 81 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2020 | 295 | 0.120 |
Why?
|
| Candidiasis | 1 | 2016 | 39 | 0.120 |
Why?
|
| Disinfection | 1 | 2016 | 16 | 0.120 |
Why?
|
| Technology | 1 | 2016 | 33 | 0.120 |
Why?
|
| Equipment Contamination | 1 | 2016 | 29 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 188 | 0.120 |
Why?
|
| Food Service, Hospital | 1 | 2016 | 4 | 0.120 |
Why?
|
| Endosonography | 1 | 2016 | 100 | 0.120 |
Why?
|
| Surveys and Questionnaires | 3 | 2025 | 2802 | 0.120 |
Why?
|
| Civil Defense | 1 | 2015 | 11 | 0.110 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 12 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 2015 | 60 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Fungi | 1 | 2015 | 67 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 87 | 0.110 |
Why?
|
| Cystectomy | 1 | 2015 | 113 | 0.110 |
Why?
|
| Radio Frequency Identification Device | 1 | 2013 | 4 | 0.100 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2013 | 17 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2019 | 822 | 0.100 |
Why?
|
| Public Health | 1 | 2015 | 153 | 0.100 |
Why?
|
| Intention | 1 | 2013 | 52 | 0.100 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 237 | 0.100 |
Why?
|
| Bacteria | 1 | 2017 | 509 | 0.100 |
Why?
|
| Research Design | 1 | 2016 | 617 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 1922 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1713 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 378 | 0.090 |
Why?
|
| Registries | 1 | 2016 | 990 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 112 | 0.080 |
Why?
|
| United States | 4 | 2025 | 7622 | 0.070 |
Why?
|
| Pandemics | 3 | 2023 | 873 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 452 | 0.070 |
Why?
|
| Students, Medical | 1 | 2013 | 435 | 0.070 |
Why?
|
| Fatal Outcome | 2 | 2019 | 295 | 0.060 |
Why?
|
| Male | 7 | 2021 | 44557 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2015 | 2562 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2013 | 1090 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 1321 | 0.050 |
Why?
|
| Female | 6 | 2021 | 48702 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 55 | 0.050 |
Why?
|
| Travel-Related Illness | 1 | 2021 | 3 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 31 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10164 | 0.040 |
Why?
|
| Medical Overuse | 1 | 2020 | 30 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 78 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 6930 | 0.040 |
Why?
|
| Critical Illness | 1 | 2023 | 343 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 49 | 0.040 |
Why?
|
| Benzylamines | 1 | 2019 | 17 | 0.040 |
Why?
|
| Risk Factors | 2 | 2023 | 5899 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2019 | 19 | 0.040 |
Why?
|
| Bone Marrow Examination | 1 | 2019 | 40 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 157 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 13 | 0.040 |
Why?
|
| Ferrets | 1 | 2018 | 49 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2018 | 113 | 0.030 |
Why?
|
| Primary Myelofibrosis | 1 | 2019 | 68 | 0.030 |
Why?
|
| Dementia | 1 | 2020 | 214 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 77 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2018 | 122 | 0.030 |
Why?
|
| Adult | 4 | 2023 | 27918 | 0.030 |
Why?
|
| Aged | 4 | 2018 | 20434 | 0.030 |
Why?
|
| Propionibacterium | 1 | 2017 | 6 | 0.030 |
Why?
|
| Staphylococcus | 1 | 2017 | 24 | 0.030 |
Why?
|
| Child | 2 | 2023 | 7355 | 0.030 |
Why?
|
| Inpatients | 1 | 2020 | 345 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Fungal | 1 | 2016 | 3 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 240 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2016 | 13 | 0.030 |
Why?
|
| Citrobacter freundii | 1 | 2016 | 2 | 0.030 |
Why?
|
| Hafnia alvei | 1 | 2016 | 2 | 0.030 |
Why?
|
| Klebsiella oxytoca | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sphingomonas | 1 | 2016 | 4 | 0.030 |
Why?
|
| Pseudomonas putida | 1 | 2016 | 7 | 0.030 |
Why?
|
| Stenotrophomonas maltophilia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Enterobacter cloacae | 1 | 2016 | 8 | 0.030 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 28 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 35 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 146 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2016 | 122 | 0.030 |
Why?
|
| Middle Aged | 4 | 2019 | 27573 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7061 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 329 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 402 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2015 | 51 | 0.030 |
Why?
|
| Global Health | 1 | 2016 | 208 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2016 | 199 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 537 | 0.030 |
Why?
|
| Viruses | 1 | 2015 | 64 | 0.030 |
Why?
|
| China | 1 | 2015 | 264 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 894 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 1266 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 2544 | 0.020 |
Why?
|
| Microbiota | 1 | 2017 | 425 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3054 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 206 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 296 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2017 | 0.020 |
Why?
|
| Illinois | 1 | 2011 | 520 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 364 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 3830 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1243 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 3911 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4560 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2011 | 372 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4272 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 2479 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 3220 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3829 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 28155 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9606 | 0.010 |
Why?
|